Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Guangdong Zhongsheng Pharmaceutical Co., Ltd.
—
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is led by CEO Yong Hong Chen, employs 1,757 people, headquartered in Dongguan, CN, publicly traded since 2009.
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) stock trades at $26.55 with a market capitalization of $22.51B. The stock is valued at a price-to-earnings (P/E) ratio of 110.33, price-to-book of 5.62, price-to-sales of 10.12. Over the past 52 weeks the stock has ranged between $16.60 and $34.27, and currently trades 22.5% below its 52-week high. It pays a dividend yielding 0.76%.
On profitability, Guangdong Zhongsheng Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 4.64%, an operating margin of 2.24%, a net profit margin of 8.96%.
The balance sheet shows a debt-to-equity ratio of 0.03 (debt below half of shareholders' equity), a current ratio of 4.86.
002317.SZ has an average daily trading volume of 32,926,418 shares, a beta of 0.60 (historically less volatile than the overall market), 0.85B shares outstanding.
Official website: www.zspcl.com
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) — frequently asked questions
What is Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) stock price today?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317.SZ) is currently trading at $26.55, down 2.68% today.
What is 002317.SZ P/E ratio?
Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s P/E ratio is 110.33. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 002317.SZ return on equity (ROE)?
Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s return on equity (ROE) is 4.64%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s market cap?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. has a market capitalization of $22.51B.
Does 002317.SZ pay a dividend?
Yes. Guangdong Zhongsheng Pharmaceutical Co., Ltd. currently yields 0.76%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002317.SZ carry?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.03. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002317.SZ's profit margin?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. reports a net profit margin of 8.96% — the share of revenue left after every cost, including tax and interest.
What sector is 002317.SZ in?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002317.SZ listed on?
Guangdong Zhongsheng Pharmaceutical Co., Ltd. trades on SHZ under the ticker 002317.SZ.
What is 002317.SZ's 52-week range?
Over the last year Guangdong Zhongsheng Pharmaceutical Co., Ltd. has traded between $16.60 and $34.27.
Related — Stocks
Popular Stocks
Screens 002317.SZ currently matches
On the figures above, Guangdong Zhongsheng Pharmaceutical Co., Ltd. passes the filters for 12 of our ready-made screens, among them Low Debt Stocks, Large Cap Stocks, Debt Free Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.